Table of Contents
International Journal of Proteomics
Volume 2014, Article ID 129259, 9 pages
http://dx.doi.org/10.1155/2014/129259
Research Article

In-Depth Profiling of the Peripheral Blood Mononuclear Cells Proteome for Clinical Blood Proteomics

1Proteome Sciences R&D GmbH & Co. KG, Altenhöferallee 3, 60438 Frankfurt am Main, Germany
2Proteome Sciences Plc, Coveham House, Downside Bridge Road, Cobham KT11 3E, UK

Received 17 October 2013; Revised 10 January 2014; Accepted 20 January 2014; Published 3 March 2014

Academic Editor: Djuro Josic

Copyright © 2014 Saša Končarević et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. J. Haudek-Prinz, P. Klepeisz, A. Slany et al., “Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells,” Journal of Proteomics, vol. 76, pp. 150–162, 2012. View at Publisher · View at Google Scholar
  2. M. Nowak, M. Klink, E. Glowacka et al., “Production of cytokines during interaction of peripheral blood mononuclear cells with autologous ovarian cancer cells or benign ovarian tumour cells,” Scandinavian Journal of Immunology, vol. 71, no. 2, pp. 91–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. L. Anderson and N. G. Anderson, “The human plasma proteome: history, character, and diagnostic prospects,” Molecular & Cellular Proteomics, vol. 1, no. 11, pp. 845–867, 2002. View at Google Scholar · View at Scopus
  4. C.-J. Sun, L. Zhang, and W.-Y. Zhang, “Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers,” Journal of Perinatal Medicine, vol. 37, no. 6, pp. 609–616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. Edwards, J. L. Feldman, J. Beech et al., “Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis,” Molecular Medicine, vol. 13, no. 1-2, pp. 40–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Bluth, Y.-Y. Lin, H. Zhang, D. Viterbo, and M. Zenilman, “Use of gene expression profiles in cells of peripheral blood to identify new molecular markers of acute pancreatitis,” Archives of Surgery, vol. 143, no. 3, pp. 227–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. R. Whitney, M. Diehn, S. J. Popper et al., “Individuality and variation in gene expression patterns in human blood,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 1896–1901, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. N. C. Twine, J. A. Stover, B. Marshall et al., “Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma,” Cancer Research, vol. 63, no. 18, pp. 6069–6075, 2003. View at Google Scholar · View at Scopus
  9. A. Belle, A. Tanay, L. Bitincka, R. Shamir, and E. K. O'Shea, “Quantification of protein half-lives in the budding yeast proteome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 35, pp. 13004–13009, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Vergara, F. Chiriacò, R. Acierno, and M. Maffia, “Proteomic map of peripheral blood mononuclear cells,” Proteomics, vol. 8, no. 10, pp. 2045–2051, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. V. J. Haudek, A. Slany, N. C. Gundacker, H. Wimmer, J. Drach, and C. Gerner, “Proteome maps of the main human peripheral blood constituents,” Journal of Proteome Research, vol. 8, no. 8, pp. 3834–3843, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Wang, Y. Dai, S. Qi et al., “Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics,” Rheumatology International, vol. 32, no. 3, pp. 585–593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Maccarrone, C. Rewerts, M. Lebar, C. W. Turck, and D. M. de Souza, “Proteome profiling of peripheral mononuclear cells from human blood,” Proteomics, vol. 13, no. 5, pp. 893–897, 2013. View at Google Scholar
  14. L. Dayon, A. Hainard, V. Licker et al., “Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags,” Analytical Chemistry, vol. 80, no. 8, pp. 2921–2931, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Farrah, E. W. Deutsch, G. S. Omenn et al., “A high-confidence human plasma proteome reference set with estimated concentrations in Peptideatlas,” Molecular & Cellular Proteomics, vol. 10, no. 9, 2011. View at Google Scholar · View at Scopus
  16. K. Kuhn, C. Baumann, J. Tommassen, and T. Prinz, “TMT labelling for the quantitative analysis of adaptive responses in the meningococcal proteome,” Methods in Molecular Biology, vol. 799, pp. 127–141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists,” Nucleic Acids Research, vol. 37, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Rachakonda, T. H. Pan, and W. D. Le, “Biomarkers of neurodegenerative disorders: how good are they?” Cell Research, vol. 14, no. 5, pp. 349–358, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Dayon, B. Sonderegger, and M. Kussmann, “Combination of gas-phase fractionation and ms3 acquisition modes for relative protein quantification with isobaric tagging,” Journal of Proteome Research, vol. 11, no. 10, pp. 5081–5089, 2012. View at Publisher · View at Google Scholar
  21. J. Muntel, M. Hecker, and D. Becher, “An exclusion list based label-free proteome quantification approach using an LTQ Orbitrap,” Rapid Communications in Mass Spectrometry, vol. 26, no. 6, pp. 701–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Rucevic, D. Hixson, and D. Josic, “Mammalian plasma membrane proteins as potential biomarkers and drug targets,” Electrophoresis, vol. 32, no. 13, pp. 1549–1564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Pellicanò, M. Bulati, S. Buffa et al., “Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production,” Journal of Alzheimer's Disease, vol. 21, no. 1, pp. 181–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. O. C. Maes, H. M. Schipper, H. M. Chertkow, and E. Wang, “Methodology for discovery of Alzheimer's disease blood-based biomarkers,” Journals of Gerontology A, vol. 64, no. 6, pp. 636–645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Onore, A. Enstrom, P. Krakowiak et al., “Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders,” Journal of Neuroimmunology, vol. 216, no. 1-2, pp. 126–129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Nardo, S. Pozzi, M. Pignataro et al., “Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells,” PLoS ONE, vol. 6, no. 10, Article ID e25545, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Shipkova and E. Wieland, “Peripheral biomarkers as a complementary tool to TDM for individualizing immunosuppression in transplantation medicine. 3.5. Surface markers of lymphocyte activation and markers of cell proliferation,” Clinica Chimica Acta, vol. 413, no. 17-18, pp. 1338–1349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Zola, B. Swart, A. Banham et al., “CD molecules 2006—human cell differentiation molecules,” Journal of Immunological Methods, vol. 319, no. 1-2, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Murashima, Y. Takasaki, M. Ohgaki, H. Hashimoto, T. Shirai, and S. Hirose, “Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients,” Journal of Clinical Immunology, vol. 10, no. 1, pp. 28–37, 1990. View at Google Scholar · View at Scopus
  30. G. C. McAlister, E. L. Huttlin, W. Haas et al., “Increasing the multiplexing capacity of tmts using reporter ion isotopologues with isobaric masses,” Analytical Chemistry, vol. 84, no. 17, pp. 7469–7478, 2012. View at Google Scholar
  31. H. L. Byers, J. Campbell, P. van Ulsen et al., “Candidate verification of iron-regulated Neisseria meningitidis proteins using isotopic versions of tandem mass tags (TMT) and single reaction monitoring,” Journal of Proteomics, vol. 73, no. 2, pp. 231–239, 2009. View at Publisher · View at Google Scholar · View at Scopus